Clinical Trial Update: The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effects of sirolimus in patients with dilated cardiomyopathy co-infected with Kaposi Sarcoma-associated herpesvirus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Kaposi Sarcoma-associated Herpesvirus Infection

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Tongji Hospital | Conditions: Dilated Cardiomyopathy, Kaposi's Sarcoma-Associated Herpesvirus Infection | Phase 4 | Status: RECRUITING